Literature DB >> 11858154

Deterioration of left ventricular function following atrio-ventricular node ablation and right ventricular apical pacing in patients with permanent atrial fibrillation.

T Szili-Torok1, G P Kimman, D Theuns, D Poldermans, J R T C Roelandt, L J Jordaens.   

Abstract

AIMS: Transcatheter radiofrequency ablation of the atrio-ventricular (AV) node followed by ventricular pacing has been shown to improve symptoms and quality of life of patients with atrial fibrillation (AF). It is assumed that function improves, but this has been less well demonstrated. The aim of this study was to assess the long-term effect of AV node ablation and ventricular pacing on left ventricular ejection fraction (LVEF) in patients with permanent AF. METHODS AND
RESULTS: All 12 patients studied had permanent AF for at least 12 months (mean age 70 years, range 41 to 78). LVEF was determined 6 days and 3 months after AV node ablation by radionuclide ventriculography, at a paced rate of 80 beats . min (-1). Cardiac dimensions were measured by means of transthoracic echocardiography. No major changes in pharmacological therapy were made during 3 months follow-up period. LVEF showed a significant deterioration after 3 months follow-up period for the group (47.5 +/- 14.4%; 6 days after ablation vs 43.2 +/- 13.7%; 3 months after ablation, P < 0.05). There were no significant differences in left ventricular cavity dimensions directly after AV node ablation and 3 months later (LVEDD 51.2 +/- 10.7 mm vs 52.6 +/- 8.6 mm, P = NS: LVESD: 36.1 +/- 14.2 mm vs 36.6 +/- 9.7 mm, P = NS). Left atrial size did not show reduction 3 months after AV node ablation (50.8 +/- 13.6 mm vs 51.0 +/- 14.1 mm, P = NS).
CONCLUSION: The restoration of a regular ventricular rhythm following AV node ablation for patients in permanent AF does not result in improvement in left ventricular function.

Entities:  

Mesh:

Year:  2002        PMID: 11858154     DOI: 10.1053/eupc.2001.0212

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  6 in total

1.  Sudden death and its risk factors after atrioventricular junction ablation and pacemaker implantation in patients with atrial fibrillation.

Authors:  Ru-Xing Wang; Hon-Chi Lee; Jia-Ping Li; David O Hodge; Yong-Mei Cha; Paul A Friedman; Thomas M Munger; Komandoor Srivathsan; Behzad B Pavri; Win-Kuang Shen
Journal:  Clin Cardiol       Date:  2016-10-17       Impact factor: 2.882

2.  Atrioventricular nodal ablation versus antiarrhythmic drugs after permanent pacemaker implantation for bradycardia-tachycardia syndrome.

Authors:  Yasutsugu Nagamoto; Tomohito Inage; Teruhisa Yoshida; Tomohiro Takeuchi; Takeki Gondo; Yujiro Fukuda; Eiichi Takii; Kenta Murotani; Tsutomu Imaizumi
Journal:  Heart Vessels       Date:  2011-04-20       Impact factor: 2.037

3.  Atrioventricular Nodal Catheter Ablation in Atrial Fibrillation Complicating Congestive Heart Failure.

Authors:  Osmar Antonio Centurión; Karina Elizabeth Scavenius; Laura B García; Luis Miño; Judith Torales; Orlando Sequeira
Journal:  J Atr Fibrillation       Date:  2018-06-30

4.  Revisiting right atrial isolation rationale for atrial fibrillation: functional anatomy of interatrial connections.

Authors:  Gerard M Guiraudon; Douglas L Jones; Allan Skanes; Edward Tweedie; George J Klein
Journal:  J Interv Card Electrophysiol       Date:  2013-04-17       Impact factor: 1.900

5.  Two-Year Follow-up in Atrial Fibrillation Patients Referred for Catheter Ablation of the Atrioventricular Node.

Authors:  Moisés Rodríguez-Mañero; Claudia Pujol Salvador; Luis Martínez-Sande; Carlo de Asmundis; Gian-Battista Chierchia; Alfonso Macías Gallego; Xulio A Fernández-López; Juan José Gavira-Gómez; Javier García-Seara; Naira Calvo; Pedro Brugada; José Ramón González-Juanatey; Ignacio García-Bolao
Journal:  J Atr Fibrillation       Date:  2014-02-28

6.  Evolution of curative therapies for atrial fibrillation review.

Authors:  Atul Khasnis; Srikar Veerareddy; Krit Jongnarangsin; John H Ip; George S Abela; Ranjan K Thakur
Journal:  Indian Pacing Electrophysiol J       Date:  2004-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.